Meril Life Sciences receives CE mark for Bioresorbable Scaffold
India | News | 0 Comment | 06 Aug, 2019
Meril Life Sciences announced that MeRes100 BRS, its indigenously designed and manufactured scaffold, became the first t...Read more
Exelixis, Aurigene to develop novel therapies for cancer
India | News | 0 Comment | 05 Aug, 2019
US based Exelixis has entered into an exclusive collaboration, option and license agreement with Aurigene Discovery...Read more
Indian’s big pharma companies finding new growth opportunities in China
India | Analysis | 1 Comment | 31 Jul, 2019
Indian pharmaceutical companies are finding lucrative opportunities for growth in the Chinese pharma market, which is se...Read more
Biological E and GVK BIO announce strategic R&D partnership
India | News | 0 Comment | 31 Jul, 2019
GVK BIO, a global Contract Research and Development Organisation (CRDO), and BE Pharmaceuticals Inc (BE Inc), a rapidly ...Read more
Strides enters into JV with Sihuan Pharma
India | News | 0 Comment | 30 Jul, 2019
Indian firm Strides Pharma Science Limited has announced that its step down subsidiary Strides Pharma Global Pte, Singap...Read more
Alvotech, Cipla Gulf to commercialise key biosimilar in few emerging markets
India | News | 0 Comment | 29 Jul, 2019
Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC, a wholly-owned subsidiary of the leading India headquartered p...Read more
Dr. Reddy's announces launch of Ramelteon Tablets in the U.S. Market
India | News | 0 Comment | 23 Jul, 2019
Dr. Reddy’s Laboratories Ltd. has announced the launch of Ramelteon Tablets, 8 mg, a therapeutically equivalent ge...Read more
Fossil Remedies to launch innovative franchise pharma platform
India | News | 1 Comment | 18 Jul, 2019
Fossil Remedies, a manufacturer and marketer of pharmaceutical products in the healthcare industry in Ahmedabad, In...Read more
Hope for restoring sight in acid attack victims
India | News | 0 Comment | 15 Jul, 2019
For the first time a tissue-softening enzyme, collagenase, will be used in patients who have suffered acid attacks or in...Read more
Takeda expands India portfolio of rare disease therapies
India | News | 0 Comment | 15 Jul, 2019
Takeda has announced the launch of its Enzyme Replacement Therapy portfolio for Lysosomal Storage Disorders (LSD) in Ind...Read more
Glenmark & Torrent to co-market diabetic drug in India
India | News | 0 Comment | 12 Jul, 2019
Glenmark Pharmaceuticals Ltd. (Glenmark), and Torrent Pharmaceuticals Limited (Torrent) have announced that they have en...Read more
Lupin launches Imatinib Mesylate tablets
India | News | 0 Comment | 09 Jul, 2019
Pharma major Lupin Limited (Lupin) announced the launch of Imatinib Mesylate Tablets, 100 mg (base) and 400 mg (base). L...Read more
Glenmark receives ANDA approval for Ranolazine Extended-Release Tablets
India | News | 0 Comment | 09 Jul, 2019
Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration for Ra...Read more
Accutest Biologics Private Limited (ABPL) wins OECD GLP certification
India | News | 0 Comment | 09 Jul, 2019
Accutest Biologics Private Limited (ABPL), a leading India-based contract research company (SRC) dedicated to biochemica...Read more
Alembic Pharma gets USFDA nod for Clonazepam to treat seizures
India | News | 0 Comment | 02 Jul, 2019
Alembic Pharmaceuticals Limited has received approval from the US Food & Drug Administration (USFDA) for its Abbrevi...Read more
World Bank provides $400M to eliminate TB in India
India | News | 0 Comment | 01 Jul, 2019
The World Bank and the Government of India have signed a loan agreement of $400 million for the Program Towards Eliminat...Read more
Glenmark receives ANDA approval for Ezetimibe and Simvastatin Tablets
India | News | 0 Comment | 28 Jun, 2019
Glenmark Pharmaceuticals has been granted final approval by the USFDA for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg...Read more
Sun Pharma enters into two agreements with China Medical System
India | News | 0 Comment | 28 Jun, 2019
Indian firm Sun Pharmaceutical has announced that one of its wholly owned subsidiaries has entered into two exclusive li...Read more